Aging Immune Cells May Undermine a Promising Cancer Therapy, Review Warns
A new review argues that immune aging and manufacturing stress, not just tumor biology, explain why gamma-delta T cell cancer ...
A new review argues that immune aging and manufacturing stress, not just tumor biology, explain why gamma-delta T cell cancer ...
A new review outlines how combining PARP inhibitors with immune checkpoint inhibitors can convert immunologically cold ovarian tumors into hot ...
Scientists have engineered the envelope protein of human endogenous retrovirus-K to break immune tolerance and drive anti-tumor responses across multiple ...
A new review argues that the immune checkpoint VISTA acts as a myeloid-centered axis in tumors, offering a route past ...
Researchers developed a random forest model integrating six clinical, inflammatory and molecular predictors that forecasts immunotherapy response in advanced lung ...
A new meta-analysis of nearly 12,000 patients links early-day immune checkpoint inhibitor infusions with markedly better survival in advanced solid ...
An editorial from Clinical Cancer Bulletin maps the converging technologies — TCR-T cells, cancer organoids, multi-specific antibody-drug conjugates, nanotechnology, and ...
A new review in Cancer Reports details how the senescence-associated secretory phenotype can both suppress and fuel tumors, and how ...
Researchers at Bar-Ilan University and the Weizmann Institute used computational protein design to create an enhanced T-cell receptor, called SET, ...
Researchers at Peking University have developed a single-cell method showing that low α2,6-linked sialylation marks the most potent tumor-reactive CD8+ ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine